Inactive Instrument

Company Standard BioTools Inc.

Equities

SLGC

US83444K1051

Biotechnology & Medical Research

Business Summary

SomaLogic, Inc. is a commercial-stage proteomics company. The Company has built an integrated proteomics platform, which offers throughput proteomics analysis with broad proteome coverage. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein. It offers SomaScan services, which provide multiplex protein detection and quantification of protein levels in complex biological samples. Its products include SomaScan Assay, SomaScan Certified Sites, SomaSignal Tests and SOMAmer Reagents. SomaScan Assay is utilized for Research Use Only (RUO) applications. Its SomaScan Assay measures approximately 7,000 protein target measurements in a single sample. Its SOMAmer reagents are proprietary modified aptamers, which are short, synthetic single-stranded DNA (ssDNA) sequences developed to bind specific protein targets with high affinity and specificity across the proteome.

Number of employees: 451

Managers

Managers TitleAgeSince
Chief Executive Officer 61 Jan. 04

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer 61 Jan. 04
Director/Board Member 55 Jan. 04
Director/Board Member 53 Jan. 04

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 188,071,546 175,755,150 ( 93.45 %) 0 93.45 %

Company contact information

SomaLogic, Inc.

2945 Wilderness Place

80301, Boulder

+

http://www.somalogic.com
address Standard BioTools Inc.(SLGC)